SUNESIS PHARMACEUTICALS (SNSS) Covered Calls

SUNESIS PHARMACEUTICALS covered calls Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.

You can sell covered calls on SUNESIS PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SNSS (prices last updated Mon 2:20 PM ET):

SUNESIS PHARMACEUTICALS (SNSS) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.14 -0.09 1.12 1.14 93K - 0.0B
Covered Calls For SUNESIS PHARMACEUTICALS (SNSS)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 1 0.25 0.89 12.4% 137%
Jan 18 1 0.30 0.84 19.0% 114%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Sunesis Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company primarily engages in development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Its efforts are currently focused primarily on the development of vosaroxin for the treatment of acute myeloid leukemia. The company's primary activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. Sunesis Pharmaceuticals was founded on February 10, 1998 and is headquartered in South San Francisco, CA.